EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Oncotarget

ISSN 1949-2553 · Impact Journals, LLC

Latest articles

  1. A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence

    Emily Bivens, Omar Atiq, Teresa Evans, Milan Bimali, Ginger Brown, Jasmine Crane, Nadia Darwish, Jennifer L. Faulkner, Rangaswamy Govindarajan, Aaron Johnson, Alongkorn Kurilung, Oxana Lazarenko, Yong-Chen William Lu, Keanna Marsh, Mauricio Moreno, Intawat Nookaew, Michael Robeson, Jumin Sunde, David Ussery, Emre Vural, Mindy Wilman, Mayumi Nakagawa

    Published: 2026-06-05DOI: 10.18632/oncotarget.28892

Volumes

2026 · 992025 · 1312024 · 1262023 · 1792022 · 1592021 · 2592020 · 4192019 · 7432018 · 3,3082017 · 9,6532016 · 6,5912015 · 3,5292014 · 1,0212013 · 2522012 · 1862011 · 1552010 · 90

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.